Table 2.
Summary of HbA1c (%) by visit and treatment
| Time from randomization | HbA1c, % | |
|---|---|---|
| Insulin detemir | NPH insulin | |
| Week –2 | 8.6 (7.3; 10.3) | 9.0 (7.1; 10.5) |
| Week 8 | 7.7 (6.2; 10.2) | 8.1 (6.2; 11.9) |
| Week 16 | 7.5 (5.7; 9.6) | 7.8 (6.2; 9.7) |
| Week 26 | 7.9 (5.3; 10.9) | 8.1 (5.9; 11.0) |
Data are median (min; max)
FAS full analysis set, NPH neutral protamine Hagedorn